Smaller firms should heed scientific advice to improve chances of success, says EMEA
This article was originally published in SRA
Executive Summary
Since the European Medicines Agency opened its office for micro-, small- and medium-sized enterprises three years ago, 38 such companies have submitted marketing authorisation applications for new products, of which 33 were for human-use drugs and five for veterinary medicines, according to the office’s latest report1.